Xeno Transplants Corporation
XENO · OTC
6/30/2007 | 6/30/2006 | 6/30/2005 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | 5.08 | -0.21 | 0.00 |
| FCF Yield | -1.39% | -2.89% | -5.83% |
| EV / EBITDA | -309.61 | -20.59 | -19.84 |
| Quality | |||
| ROIC | 33.21% | -372.54% | 95.36% |
| Gross Margin | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.01 | 0.57 | 1.20 |
| Growth | |||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% |
| Free Cash Flow Growth | -1,909.55% | 29.83% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | 0.25 | 0.00 | 0.85 |
| Interest Coverage | 0.00 | 0.00 | 194.91 |
| Efficiency | |||
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 |